Town & Country Bank & Trust CO dba First Bankers Trust CO cut its stake in Clorox Co (NYSE:CLX) by 10.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,816 shares of the company’s stock after selling 1,025 shares during the period. Town & Country Bank & Trust CO dba First Bankers Trust CO’s holdings in Clorox were worth $1,339,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors also recently made changes to their positions in CLX. Heritage Wealth Advisors purchased a new stake in Clorox in the 2nd quarter valued at about $30,000. Transamerica Financial Advisors Inc. purchased a new stake in shares of Clorox in the 2nd quarter valued at $41,000. Mirova purchased a new stake in shares of Clorox in the 2nd quarter valued at $47,000. Nelson Van Denburg & Campbell Wealth Management Group LLC boosted its holdings in shares of Clorox by 45.9% in the 3rd quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 334 shares of the company’s stock valued at $50,000 after acquiring an additional 105 shares during the last quarter. Finally, Prestige Wealth Management Group LLC purchased a new stake in shares of Clorox in the 2nd quarter valued at $53,000. 78.18% of the stock is owned by hedge funds and other institutional investors.
Several analysts have recently commented on CLX shares. ValuEngine downgraded shares of Clorox from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Barclays reaffirmed a “sell” rating on shares of Clorox in a report on Friday, October 4th. Wells Fargo & Co reaffirmed a “hold” rating and issued a $150.00 price objective on shares of Clorox in a report on Wednesday, October 2nd. JPMorgan Chase & Co. reaffirmed an “underweight” rating and issued a $137.00 price objective (down from $143.00) on shares of Clorox in a report on Thursday, October 3rd. Finally, Royal Bank of Canada upped their price objective on shares of Clorox to $161.00 and gave the company a “sector perform” rating in a report on Friday, August 2nd. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $152.25.
NYSE CLX traded down $0.31 during mid-day trading on Friday, reaching $150.44. 9,363 shares of the stock were exchanged, compared to its average volume of 1,172,253. The company has a debt-to-equity ratio of 4.09, a quick ratio of 0.55 and a current ratio of 0.91. The company has a market capitalization of $18.79 billion, a P/E ratio of 23.85, a P/E/G ratio of 5.05 and a beta of 0.40. Clorox Co has a 1 year low of $141.53 and a 1 year high of $167.70. The business’s 50 day moving average is $155.39 and its 200-day moving average is $155.38.
Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 1st. The company reported $1.88 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.84 by $0.04. The business had revenue of $1.63 billion for the quarter, compared to the consensus estimate of $1.69 billion. Clorox had a net margin of 13.20% and a return on equity of 118.88%. The company’s revenue was down 3.8% compared to the same quarter last year. During the same period last year, the firm posted $1.66 earnings per share. Equities analysts predict that Clorox Co will post 6.14 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Wednesday, October 30th will be given a $1.06 dividend. This represents a $4.24 dividend on an annualized basis and a dividend yield of 2.82%. The ex-dividend date of this dividend is Tuesday, October 29th. Clorox’s dividend payout ratio (DPR) is 67.09%.
In other news, SVP Michael R. Costello sold 6,997 shares of the stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $162.56, for a total value of $1,137,432.32. Following the completion of the sale, the senior vice president now directly owns 29,016 shares in the company, valued at $4,716,840.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Diego J. Barral sold 1,987 shares of the stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $157.59, for a total transaction of $313,131.33. The disclosure for this sale can be found here. Insiders sold 15,609 shares of company stock valued at $2,497,443 over the last quarter. Company insiders own 1.14% of the company’s stock.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Article: What is insider trading?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.